title: Bioreductively activated lysyl oxidase inhibitors against hypoxic tumours.
authors.affiliation: Dipartimento di Scienze Farmaceutiche, Università di Pisa, Via Bonanno 6, I-56126 Pisa (Italy).
authors.forename: Carlotta
authors.initials: C
authors.lastname: Granchi
authors.forename: Tiziana
authors.initials: T
authors.lastname: Funaioli
authors.forename: Janine T
authors.initials: JT
authors.lastname: Erler
authors.forename: Amato J
authors.initials: AJ
authors.lastname: Giaccia
authors.forename: Marco
authors.initials: M
authors.lastname: Macchia
authors.forename: Filippo
authors.initials: F
authors.lastname: Minutolo
mesh_terms: D000629:Aminopropionitrile / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D015687:Cell Hypoxia / Q000187:drug effects; D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D000860:Hypoxia / Q000201:enzymology*; D009369:Neoplasms / Q000201:enzymology*; D010084:Oxidation-Reduction; D011355:Prodrugs / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D008249:Protein-Lysine 6-Oxidase / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D011355:Prodrugs; D000629:Aminopropionitrile; D008249:Protein-Lysine 6-Oxidase
references.citation: Med Res Rev. 2009 Jan;29(1):29-64
references.pmid: 18688784
references.citation: Proc Soc Exp Biol Med. 1955 Jun;89(2):294-7
references.pmid: 14395297
references.citation: Cell Mol Life Sci. 2006 Oct;63(19-20):2304-16
references.pmid: 16909208
references.citation: Cancer Res. 2006 Nov 1;66(21):10238-41
references.pmid: 17079439
references.citation: Front Biosci. 1998 May 01;3:A23-6
references.pmid: 9563974
references.citation: Int J Exp Pathol. 1992 Oct;73(5):613-24
references.pmid: 1358170
references.citation: J Am Chem Soc. 2006 Jan 11;128(1):245-9
references.pmid: 16390153
references.citation: Curr Mol Med. 2003 Nov;3(7):659-71
references.pmid: 14601640
references.citation: Mol Cell Biol. 2004 Apr;24(7):2875-89
references.pmid: 15024076
references.citation: Cancer Res. 2004 Apr 1;64(7):2552-60
references.pmid: 15059911
references.citation: ChemMedChem. 2008 Mar;3(3):435-44
references.pmid: 18064617
references.citation: J Biol Chem. 1987 Oct 25;262(30):14520-4
references.pmid: 2889728
references.citation: J Biol Chem. 1989 Aug 5;264(22):12963-9
references.pmid: 2568990
references.citation: Cancer Cell. 2009 Jan 6;15(1):35-44
references.pmid: 19111879
references.citation: Drug Discov Today. 2008 Apr;13(7-8):285-94
references.pmid: 18405840
references.citation: Biochem Biophys Res Commun. 1972 Jan 31;46(2):745-51
references.pmid: 5057904
references.citation: J Biol Chem. 2005 Jul 1;280(26):24690-7
references.pmid: 15843371
references.citation: Oncol Res. 1997;9(6-7):357-69
references.pmid: 9406242
references.citation: Mutagenesis. 2005 May;20(3):193-7
references.pmid: 15817571
references.citation: Chemistry. 2007;13(11):3218-26
references.pmid: 17200920
references.citation: J Biol Chem. 1997 Dec 19;272(51):32370-7
references.pmid: 9405445
references.citation: Nat Rev Cancer. 2004 Jun;4(6):437-47
references.pmid: 15170446
references.citation: Drug Discov Today. 2006 Feb;11(3-4):175-80
references.pmid: 16533716
references.citation: Nature. 2006 Apr 27;440(7088):1222-6
references.pmid: 16642001
references.citation: J Biol Chem. 1984 Jan 25;259(2):975-9
references.pmid: 6141164
references.citation: PLoS One. 2009;4(5):e5620
references.pmid: 19440335
references.citation: Toxicology. 2002 Aug 15;177(2-3):267-84
references.pmid: 12135629